These trials eliminate the physical burden of travel by delivering medicine to the participant's home. This makes it easier for patients to participate in the study while maintaining their daily routines.
Key Takeaways
The Retention Revolution: Travel barriers, particularly in an archipelago nation like Indonesia, are the primary reason for a 30% patient study dropout rate. Moving the clinical trial site to the patient's home can eliminate this obstacle.
BPOM Regulatory Readiness: The Indonesian Food and Drug Administration (BPOM) continues to strengthen the clinical trial ecosystem in Indonesia. These regulations demand a guaranteed Quality by Design approach.
Unbroken Chain of Custody: Maintaining the stability of unapproved drugs outside a clinic requires IoT sensors and trusted specialised delivery.
Scalable Compliance: Success in Indonesia means being able to manage various permits from BPOM and reach remote locations throughout the archipelago.
Traditional clinical trial models centred on dedicated trial sites face significant challenges in 2026. Recruitment targets are frequently missed because patients cannot arrange time and travel for hospital visits, particularly given Indonesia's geography of thousands of islands. We have built the DHL Health Logistics network to directly address this challenge. Our 2-billion-euro investment ensures you have GDP-certified infrastructure and specialised handling needed to reach patients wherever they are. Direct-to-Patient (DtP) clinical trials move the laboratory to the patient's living room while maintaining the highest safety standards.
Why is patient retention the biggest risk in clinical research in 2026?
Travel is the primary reason participants abandon clinical studies. When you move the trial site to the patient's home, you reduce missed visits and screening failures, which are significant challenges in a geographically vast archipelago.
Travel Distance: Cancer trial patients travel a median distance of nearly 42 miles for Phase I studies.
Rural Hurdles: Participants in remote areas, such as on outer islands of Java, often must travel more than 100 miles each way, sometimes between islands.
Human Connection: Our technical couriers act as a professional extension of the clinical trial site at the patient's doorstep, building the trust that is crucial.
Supportive Experience: Our premium services go beyond simple delivery; they build participant confidence and provide peace of mind.
DHL Health Logistics provides the professional bridge between your laboratory and participants. We understand that the courier is often the only face of the trial that a patient sees, and we honour that trust.
What are the 2026 regulatory requirements for DtP?
Regulators in Indonesia, led by the Indonesian Food and Drug Administration (BPOM), are actively strengthening the framework to support decentralised models. Guidelines such as Good Clinical Trial Practice (GCTP) require you to demonstrate that medicine remains stable from the depot to the patient's refrigerator.
Regulatory Framework: BPOM requires all clinical trials to obtain Clinical Trial Implementation Approval (PPUK) before commencing, ensuring strict oversight of patient safety.
Strict Accountability: To obtain PPUK and Import Permit Letter (SKI) for clinical trial products, BPOM demands complete and verifiable temperature records.
Thermal Protection: Our advanced shippers maintain temperatures of 2 to 8°C or -20°C for up to 120 hours, critical for long-distance delivery in Indonesia's tropical climate.
Digital Proof: IoT sensors transmit live data to show exactly when a participant receives the shipment, providing a clear audit trail for BPOM.
Our investment in digital tools ensures you have a complete thermal audit trail. This transparency is a mandatory requirement to satisfy quality assurance teams in 2026.
How do you handle medical licensing restrictions in developing markets?
Sending unapproved drugs to a private address is strictly regulated in Indonesia. You need a partner who understands the intricacies of regulations from the Ministry of Health and BPOM.
Health Reforms: Indonesia is undergoing major structural reforms to its healthcare system, which affects how clinical trial materials are imported and distributed.
Complex Permitting Process: Obtaining import approval from BPOM requires careful documentation. With the right partner, a process that normally takes weeks can be accelerated by ensuring all documents are prepared completely and accurately from the start.
Expert Navigation: Our local specialists work with organisations like BPOM and the Directorate General of Customs and Excise (Bea dan Cukai) to ensure the smooth operation of your clinical trial. We help manage the often complex multi-ministry documentation process.
Expanded Footprint: Proper licensing allows you to reach regions across the archipelago that were previously considered too complicated, from Sumatra to Papua.
Can you guarantee a secure chain of custody at the doorstep?
Security and privacy are paramount when delivering sensitive products to a home. You must ensure the medicine is handed directly to the verified participant or their authorised representative.
Identity Verification: We check ID cards against clinical trial records before any package is handed over.
Point-of-Use Delivery: Couriers place the medicine directly into the participant's storage or refrigerator.
Instruction Support: We ensure the patient knows how to handle the packaging.
Safe Disposal: We collect used kits or sharp containers for medical-grade destruction.
What is the role of reverse logistics in home-based trials?
A DtP clinical trial does not end at the doorstep. You must also manage the flow of biological samples and unused medicines back to the central laboratory.
Stability Windows: Blood or urine samples must be collected and returned within strict time limits to maintain their integrity.
Data Integrity: If a sample's temperature becomes elevated during transit, clinical trial data can become invalid.
Remote Reach: We use specialised transport to reach participants in remote locations across the Indonesian archipelago, ensuring every sample returns safely.
Unified Visibility: A clinical research associate in Jakarta can see the same data as a sponsor in London, providing a clear and integrated view.
Ready to streamline your clinical trial strategy?
Direct-to-Patient logistics is no longer merely a future concept. It is the best way to improve patient experience and protect the integrity of your data. DHL Health Logistics is ready to help you scale your research across the Indonesian region. Speak to a DHL specialist today to review your clinical trial plan and reach your participants with full confidence.
Frequently Asked Questions
These upcoming guidelines require sponsors to use a Quality by Design approach. You must have digital proof that investigational products remained stable during the entire journey to the patient's home.
We use real-time IoT sensors that transmit location and temperature data directly to a dashboard. This ensures you receive an immediate alert if the shipment deviates from the required temperature range.
Yes, but you need a partner who understands local medical licensing and the complexities of archipelago logistics. Using a standardised digital platform ensures your data remains comparable across regions, from urban centres in Java to remote communities in Eastern Indonesia.
Yes, our couriers follow a verified delivery protocol. This includes checking the participant's identification to ensure the sensitive medicine is handed to the correct person.
Share
Similar Stories
